Conclusions
PC is rare and challenging to recognize skin cancer with a high risk of recurrence and metastasis. Despite its rarity, eccrine PC is the most common sweat gland. The differential diagnosis for every suspicious cutaneous lesion is needed to prevent delays in treatment.
Our clinical case suggests that early identification and complete excision offer the best chances of feasible recovery even in elderly patients in poor general condition and with numerous comorbidities.
No treatment has been standardized yet. Surgery is the first and only therapeutic option that could significantly affect patient outcomes. Chemotherapy and radiotherapy have not shown clinical benefits in the management of advanced PC.
Due to its rarity, further research, including case reports, is necessary to improve the diagnosis and therapy of PC.